Kang; Liqing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kang; Liqing.The latest application filed is for "octs technology-based pancreatic cancer and malignant mesothelioma car-t therapeutic vector, construction method therefor, and u".

Company Profile

9.6.6

Kang; Liqing - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
siRNA knocking down human PD-1 and recombinant expression CAR-T vector and their construction methods and applications Grant 11,242,530 - Yu , et al. February 8, 2	2022-02-08
OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic vector, construction method therefor, and use thereof Grant 11,098,123 - Qi , et al. August 24, 2	2021-08-24
IL6R block CAR-T transgenic vector for alleviating CRS, preparation method thereof Grant 11,066,680 - Yu , et al. July 20, 2	2021-07-20
Malignant glioma CAR-T therapeutic vector based on OCTS technology, and construction method and application thereof Grant 10,934,357 - Qi , et al. March 2, 2	2021-03-02
PDL1 block CAR-T transgenic vector for suppressing immune escape, preparation method thereof, and application of the same Grant 10,736,920 - Yu , et al. A	2020-08-11
SiRNA of human IL-6 and recombinant expression CAR-T vector and their construction methods and applications Grant 10,702,552 - Yu , et al.	2020-07-07
Octs Technology-based Pancreatic Cancer And Malignant Mesothelioma Car-t Therapeutic Vector, Construction Method Therefor, And U App 20200181269 - QI; Wei ; et al.	2020-06-11
Malignant Glioma Car-t Therapeutic Vector Based On Octs Technology, And Construction Method And Application Thereof App 20200181268 - QI; Wei ; et al.	2020-06-11
Il6r Block Car-t Transgenic Vector For Alleviating Crs, Preparation Method Thereof, And Application Of The Same App 20190292564 - QI; Wei ; et al.	2019-09-26
Pdl1 Block Car-t Transgenic Vector For Suppressing Immune Escape, Preparation Method Thereof, And Application Of The Same App 20190290693 - QI; Wei ; et al.	2019-09-26
siRNA knocking down Human PD-1 and Recombinant Expression CAR-T Vector and Their Construction Methods and Applications App 20190218559 - QI; Wei ; et al.	2019-07-18
siRNA of Human IL-6 and Recombinant Expression CAR-T Vector and Their Construction Methods and Applications App 20190201445 - QI; Wei ; et al.	2019-07-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.